$ITRI

Reeves Donald L. III sold $27K of ITRI

Reeves Donald L. III (SVP, Outcomes) sold 319 shares of ITRON, INC. (ITRI) at $84.37 on 2026-05-26.

Original reporting
SEC EDGAR · Reeves Donald L. III
Published May 27, 2026, 9:49 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ITRI
Neutral
medium confidence
Mentioned
$ITRI
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ITRINeutralLow
01

Why it matters

A single officer open-market sale may create minor bearish sentiment, but there is no evidence of a broader change in company prospects.

02

Market read

Traders may briefly monitor for insider-selling patterns, but this specific disclosure is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

The article provides only one small sale; without a pattern of multiple insider sales or concurrent positive/negative company news, signal quality is low.

Relevance 6/10Timing: Immediate (same-day disclosure), but effect likely fades quickly absent follow-on news.

Background

The article reports a Form 4 insider transaction for Itron, Inc. (ITRI) filed on SEC EDGAR.

Company-level read

Ticker impact

$ITRINeutralMedium confidence
Context

ITRI disclosed an officer (SVP, Outcomes) open-market sale of 319 shares at ~$84.37 on 2026-05-26 via SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely limited to intraday sentiment around insider selling.

Evidence & confidence

Insider transactions on Form 4 often reflect diversification or personal liquidity; the disclosed size (~$27K) is small relative to typical daily liquidity, and there is no accompanying operational or financial catalyst in the article.

Market effects

Minimal—this is company-specific insider activity with no sector-wide signal described.

None indicated.

None indicated.

Counterpoint

The sale could be diversification or tax-related; absence of a 10b5-1 plan does not necessarily imply negative outlook.

Key entities

  • ITRI

    Itron, Inc.; subject of the Form 4 insider sale disclosure.

  • Reeves Donald L. III

    SVP, Outcomes; sold 319 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VIAVMed

Inspection Instruments Stocks Q2 Earnings Review: Keysight (NYSE:KEYS) Shines

Viavi Solutions (down 10.9%) had the fastest revenue growth among inspection instruments stocks, while Badger Meter (NYSE:BMI, down 9.3%) reported a 6.6% revenue decline. Itron (NASDAQ:ITRI, up 12.2%) missed revenue estimates but exceeded EBITDA and EPS guidance. Teledyne (NYSE:TDY, down 3.7%) reported a 9.8% revenue increase, beating expectations. Market risks have shifted from AI to geopolitics and back to fundamentals.

$ITRIMedAI 8/10

Why Shares of Itron Stock Jumped 17.4% This Week

Itron shares rose about 17% this week after the company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Itron posted non-GAAP EPS of $1.59 versus $1.29 expected and cited demand for grid stability tied to AI infrastructure build-out. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMed

Why Shares of Itron Stock Jumped 17.4% This Week

Itron (NASDAQ: ITRI) shares rose about 17.4% this week, after the utility technology company reported strong Q2 results and raised full-year guidance, according to S&P Global Market Intelligence. Non-GAAP EPS was $1.59 versus $1.29 expected. Full-year EPS guidance was raised to $6.40 at the midpoint.

$ITRIMedAI 8/10

Itron Q2 Earnings Call Highlights

Itron (NASDAQ:ITRI) reported Q2 GAAP net income of $53M, or $1.19/diluted share, versus $68M a year earlier. Non-GAAP operating income rose 8% to $89M and adjusted EBITDA rose 8% to $97M. Q2 revenue by segment: Device Solutions $111M, Networked Solutions $339M, Outcomes $96M, Resiliency Solutions about $16M. Free cash flow was $81M. Backlog was $4.4B. Itron raised full-year non-GAAP EPS to $6.30-$6.50 and narrowed revenue to $2.37B-$2.41B.